Fluorescence imaging of in vivo miR-124a-induced neurogenesis of neuronal progenitor cells using neuron-specific reporters
- Jaeho Jang†1, 2,
- Song Lee†1,
- Hyun Jeong Oh1, 2,
- Yoori Choi1,
- Jae Hyouk Choi1,
- Do Won Hwang1, 2Email author and
- Dong Soo Lee1, 2Email author
© Jang et al. 2016
Received: 15 January 2016
Accepted: 15 April 2016
Published: 26 April 2016
Facilitation of the differentiation of the stem cells toward neuronal lineage is crucial for enhancing the differentiation efficacy of grafted stem cells for the possible treatment of neurodegenerative disorders. MicroRNA124a (miR-124a) has been considered as a neuronal lineage regulator, possessing the capability to activate neuronal differentiation. In this study, using a neuronal promoter-based reporter and live-cell fluorescence imaging, we visualized in vitro and in vivo the enhanced neuronal differentiation of neuronal progenitor cells with miR-124a overproduction.
The neuron specific alpha1 tubulin promoter-driven RFP reporter (pTa1-RFP) was used to trace the miR-124a-induced neuronal differentiation in live cell condition. MiR-124a or miR-scramble in 10 % glucose buffer was mixed with in vivo-jetPEITM and in vivo fluorescence images were obtained daily using Maestro spectral fluorescent imager.
Neurite outgrowth was clearly seen in F11 cells after miR-124a transfection, and immunofluorescence staining showed increase of Tuj1 and NF at 48 hours. When pTa1-RFP-transfected F11 cells were implanted simultaneously with miR-124a into the nude mice, gradually increasing reporter signals and morphological changes indicated neuronal differentiation for 48 hours in live cells in vitro. The miR-124a-treated F11 cells showed higher reporter signals on in vivo fluorescence imaging than miR-scramble-treated cells, which were verified by ex vivo confirmation of Tuj1 and NF expression.
These results indicated that neuronal reporter-based neurogenesis imaging can be used for monitoring miR-124a acting as neuronal activator when miRNA was injected in in vivo PEI-coated form for miRNA-mediated regenerative therapy.
For the intractable brain diseases, the feasibility of immunotherapy and cell-based therapy have been studied using primates or small animals [1–3]. Therapeutic strategy using stem or progenitor cells was proposed as a possibility to treat neurodegenerative disorders replacing the injured brain tissues with cell implants. Embryonic stem cells, mesenchymal stem cells, and neural stem or progenitor cells were proposed as cell candidates [4–7]. Among these cells, neural stem or progenitor cells were found promising as they are able to differentiate to neurons if implanted [8–11]. However, though these stem cells were highly expected to differentiate into neuronal cells for the success of stem cell treatment, in reality, they rarely differentiate into the desired cell lineage when implanted. Thus, investigators used a variety of potential factors to enhance the differentiation in vivo, such as neurogenin 1 (ngn1), neuroD2 (pro-neural basic helix-loop-helix transcription factors), or microRNAs [12–15].
MicroRNAs participate in post-transcriptional regulation of cellular differentiation by binding to the complementary sequences of target messenger RNAs (mRNAs) or non-coding RNAs and down-regulate their target gene expression. During developmental process, let-7 microRNAs regulate developmental timing or certain microRNAs are over-expressed or under-expressed in diseases such as cancer, metabolic diseases, and cardiovascular disorders [16–20]. MicroRNAs might be used as a tool to control the biological process of interest even for the treatment of neurodegenerative diseases. Among the variety of microRNAs expressed exclusively in the nervous system, miR-124a is abundantly expressed as neuron-specific miRNAs [21–25]. miR-124a was reported to promote neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing [26–30] and was known to participate in neuronal fate determination during spinal cord development , and miR-124a was necessary for a proper brain development and axogenesis of dentate granule neurons . miR-124a might be able to promote neuronal differentiation of stem or progenitor cells when co-administered with the stem/progenitor cell implants as a differentiation activator. If proven for its efficacy, injection of miR-124a might enhance the feasibility of using progenitor cell implants in intractable neurological disorders.
Reporter genes have been used as molecular-genetic imaging agents for monitoring various cellular biologic processes [33–35]. For visualization of neuronal differentiation using molecular imaging techniques, neuron-specific promoter-driven optical reporters can be used as simple imaging system to monitor the transition of implanted stem cells into neuronal lineage in vivo. Tα1, a member of tubulin, is expressed abundantly during neuronal development, and Tα1 mRNA is enriched in neurons undergoing active neurite extension [36, 37]. In this study, neuron-specific pTα1 promoter-driven RFP reporter system was adopted to trace the activation of neuronal differentiation in vitro and in vivo induced by the administration of exogenous miR-124a in the implants of neural progenitor or stem cells.
F11 (hybrid cell line of rat dorsal root ganglion cell with mouse neuroblastoma) and HB1.F3 (an immortalized, clonal human neural stem cell line) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Grand Island, NY) supplemented with 10 % fetal bovine serum (FBS, Invitrogen, Grand Island, NY) and 1 % antibiotics (Invitrogen, Grand Island, NY) at 5 % CO2 atmosphere.
MiRNAs and fluorescence reporter gene transfection
To promote neuronal differentiation by miR-124a, 1 × 105 of F11 or F3 cells were seeded in 12-well plates. After 24-h incubation, 50 nM of chemically modified miR-124a or miR-scramble oligomer (Life technologies, Ambion, CA) was transfected into F11 or F3 cells using a Lipofectamine reagent (Invitrogen, Grand Island, NY). For a live cell imaging, 1 × 104 of F11 or F3 cells were seeded in eight-well chamber slide (Nunc, NY). 0.2 μg of pTα1 (Talpha1 promoter)-RFP (kindly donated by Keejung Yoon, Sungyunkwan University)  and miRNA oligomer were co-transfected into F11 cells using Lipofectamine.
Immunofluorescence imaging and neurite outgrowth measurement
Cells were fixed with 4 % paraformaldehyde (USB®, OH) or 20 min at room temperature and incubated in 0.5 % hydrogen peroxide in methanol for 20 min. After phosphate buffered saline (PBS) washing, cells were incubated in 0.1 % Triton X-100 (Samchum Chemical, Seoul). Thirty minutes after blocking with 1:30 dilution of normal goat serum, 1:300 dilution of rabbit neuron-specific class III β-tubulin (Tuj1; Sigma, MO), 1:500 dilution of rabbit neurofilament (NF; Sigma, MO), 1:300 dilution of mouse glial fibrillary acidic protein (GFAP; Cell Signaling, MA), 1:300 dilution of rabbit enolase-1 (Cell Signaling, MA), and 1:300 dilution of mouse BrdU (Cell signaling, MA), these samples were incubated for 24 h at 4 °C. After washing, the cells were incubated for 1 h with 1:400 dilution of Alexa Fluor 488 anti-mouse and Alexa Fluor 555 anti-rabbit secondary antibodies (Invitrogen, CA). Sample slides were prepared with 4′,6-diamidino-2-phenylindole hydrochloride (DAPI) mounting solution (Vector Laboratories, CA). Fluorescence images were obtained, and neurite outgrowths were measured by a Zeiss 510 Meta Laser scanning microscope (LSM; Carl Zeiss Microimaging, NY).
Fluorescence live cell imaging of F11 transfected with miR-124a
For visualizing the activation of neuronal differentiation induced by the overproduction of miR-124a, 1 × 104 of F11 cells were seeded in each well of eight-well chamber slide and co-transfected with miR-124a (40 nM) and pTα1-RFP (0.2 μg). During 48 h, phase contrast and fluorescence images were obtained in a time-lapse imaging system (Olympus IX81 ZDC microscope, PA). Each image was obtained simultaneously with every 30-min intervals.
In vivo fluorescence imaging of neuronal differentiation of F11 cells co-administered with miR-124a
Immunohistochemistry of implanted mass
Implanted mass over the thighs of the nude mice were excised, and these samples containing F11 cells with miR-124a or miR-scramble were fixed with 4 % paraformaldehyde for 20 min at room temperature. The samples were embedded in paraffin block, and the paraffin block was sectioned by a rotary microtome Leica RM2145 (Leica Microsystems, Wetzlar). Ten-micrometer-thick sectioned samples were stained with primary antibodies against 1:100 dilution of rabbit RFP (Abcam Inc., MA), 1:300 dilution of rabbit Tuj1 (Sigma, MO), and 1:500 dilution of rabbit NF (Sigma, MO) overnight at 4 °C. Then, the samples were incubated with 1:400 dilution of Alexa Fluor 488 anti-mouse and Alexa Fluor 488 anti-rabbit secondary antibodies for 1 h. The sample slides were prepared with 4′,6-diamidino-2-phenylindole hydrochloride (DAPI) mounting solution and fluorescence images were obtained by a Zeiss 510 Meta Laser scanning microscope (LSM; Carl Zeiss Microimaging, NY).
Morphological changes of F11 cells treated with miR-124a
Enhanced expression of neuronal markers induced by miR-124a in F11 and F3 cells
To verify the enhanced expression of neuronal markers of F11 cells induced by the overproduction of miR-124a, we performed immunofluorescence at 48 h after miR-124a transfection using neuronal-specific antibodies Tuj1, NF, enolase, and GFAP. Neuron-specific class III β-tubulin (Tuj1) is present in newly generated immature post-mitotic neurons and differentiated neurons and in some mitotically active neuronal precursors. Neurofilaments (NFs) are the intermediate filaments found specifically in neurons. Tuj1 and NF expressions were significantly higher in miR-124a-treated F11 cells, compared to miR-scramble-treated cells (Fig. 2b). BrdU staining results showed that the population of proliferating cells decreased in miR-124a-treated F11 cells suggesting that miR-124a-induced neuronal differentiation is associated with the decreased proliferation. Enolase-1 is ubiquitously expressed in adult tissues including the brain and liver and elevated in neuroblastoma. As a marker of neuroblastoma, ubiquitously expressing enolase-1 expression was intense in both scramble- and miR-124a-treated F11 cells and glial cell marker GFAP expression was not found in both groups.
Time course of F11 cell changes showing neuronal-lineage differentiation by miR-124a on fluorescence live cell imaging in vitro
In vivo fluorescence imaging of differentiating F11 cells induced by co-administration of miR-124a to the implants
Immunohistochemistry analysis showed that expression of Tuj1, early neuronal marker and NF, and late neuronal markers increased in miR-124a-treated F11 cells, compared to those in miR-scramble-treated F11 cells (Fig. 5c).
Facilitating the neuronal differentiation from the grafted stem or progenitor cells is important to enhance therapeutic efficacy of the stem cell treatment for a variety of neurological diseases. There are many types of already known molecules enhancing neuronal differentiation such as a chemical compound (retinoic acid, cAMP), exogenous genes (neuroD2, ngn1), and non-coding RNAs [12, 13, 40–42]. Several miRNAs have been reported closely linked to regulating neuronal differentiation in the development of neurological diseases [43–45]. For example, the down-regulation of neurogenic miRNAs such as miR-9 and miR-132 leads to the impaired neurogenesis [46, 47]. MiR-124a is well-known as an essential regulator of neuronal differentiation by down-regulating the proliferation-related genes . Using miR-124a to promote neuronal differentiation may be a feasible strategy considering its definite expression difference in neural progenitor cells between pre-and post-neuronal differentiation [49, 50]. In addition, several reports demonstrated that miR-124a itself was sufficient to induce neuronal differentiation, which can even be regarded as an accelerator to induce neurogenesis [51, 52]. We assumed that the up-regulation of miR-124a expression increase the neuronal differentiation helping enhance therapeutic efficacy of stem/progenitor cell implants. If we want to prove this strategy works or not, it is important to reveal how much of the implanted progenitor cells (or stem cells) differentiate into neuronal lineage by miR-124a administration and molecular imaging method we used worked and was simple and reliable.
In our results, the immunofluorescence clearly revealed that miR-124a facilitated the differentiation toward neuronal lineage in a short period of time in neural progenitor F11 or neural stem F3 cells. The early neuronal marker Tuj1 and late neuronal marker NF levels were definitely increased in miR-124a-treated F11 cells, showing elaborate neurite formation (Fig. 2b). We also examined the dynamic time courses of reporter expression representing neuronal differentiation of F11 cells induced by miR-124a and live F11 cells provided in vitro their extent of differentiation efficiency. Neuron-like morphological changes of F11 neuronal progenitor cells after the overexpression of miR-124a complied with the Tα1 promoter-driven RFP reporter gene expression visualizing the neuronal differentiation of these cells . MiR-124a-transfected F11 cells clearly showed the gradual increase in RFP signals along with stretched cell body in live cell condition until 2 days after miR-124a transfection.
For in vivo miR-124a transfection study, we used easily available in vivo jetPEI™, which is composed of a positive charged polyethylenimine polymer, and mixed our miR-124a with this polymer transfection agent . When RFP-laden F11 cells were co-administered with PEI-miR-124a complex as an implant into each thigh of nude mouse, the similarly low RFP signals and excessive auto-fluorescence signals from the skin were observed both in miR-124a-treated and miR-scramble-treated side at 0 day. However, the fluorescence intensity in miR-124a-treated F11 cell group became higher at 4 days, compared to scramble-treated F11 cell group. In in vivo fluorescence imaging study in skin-removed mice, visually and quantitatively, the discrepancy of RFP signal between miR-124a-treated and scramble-treated group became prominent at 4 days. Ex vivo study has also confirmed that the implanted F11 cells differentiated to the neuronal lineage by the influence of miR-124a co-administered mixed with PEI in vivo. Immunohistochemistry proved the miR-124a-induced increased expression of Tuj1 and NF in the isolated section of implanted F11 cells. These finding demonstrated that exogenous miR-124a oligomer alone, when co-administered in matrix gel with the cell implants, induces the neuronal differentiation of F11 cells in nude mice. This phenomenon could be examined simply using in vivo fluorescence imaging technique.
The imaging investigation of the functional outcome of miRNA co-administration will be helpful for the evaluation of the possible in vivo effect of various miRNA or related nucleic acid oligomers (such as siRNA or gapmer). Some of them might be as a key controller of a variety of biological phenomenon such as cell differentiation. Though we just proved the effect of single microRNA (miR-124a) in this study, PEI system easily hosts cocktails of microRNAs. This easy sensing technique to report miRNA function in vivo will be attractive because of widespread applicability for elucidating unknown functions of specific miRNA.
Fluorescence-based optical imaging modality has been widely harnessed to examine time-course changes of amount of biomolecules with high resolution. Nevertheless, the intrinsic shortcoming that cannot acquire the signals in deep tissue hampers to move forward clinical application. Much effort has been made to use a longer NIR wavelength and wavefront shaping technique with the control of multiple light scattering to overcome tissue penetration issue [55, 56]. Even though our fluorescence-based approach to trace the effect of miR-124a might not give useful information non-invasively in clinic, this technique could be applied for minimal invasive intraoperative study using multiphoton microscopy to trace the course of neuronal differentiation by miR-124a in living brain tissue.
In this study, we imaged the functional outcome of miR-124a transfection to the stem/progenitor cell implants focusing on the activating the neuronal differentiation using neuron-specific promoter-based reporter gene system. In vitro live cell tracking to trace the dynamic changes of differentiation toward neuronal fate by miR-124a would have also inform us when we can expect the probable changes of cellular fate after in vivo administration despite the difference between in vitro and in vivo situation. We suggest that this approach provides invaluable information to evaluate functional outcome of cell-based therapy co-administered with neurogenic miRNAs in a variety of neurological disease model.
This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C0466), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3344), and funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277); the Technology Innovation Program (10052749) funded by the Ministry of Trade, Industry and Energy (MOTIE) of Korea; and National Research Foundation of Korea grant funded by the Korea government (MSIP) (2015M3C7A1028926).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Hart BA, Smith P, Amor S, Strijkers GJ, Blezer EL. MRI-guided immunotherapy development for multiple sclerosis in a primate. Drug Discov Today. 2006;11:58.View ArticlePubMedGoogle Scholar
- Villoslada P, Moreno B, Melero I, Pablos JL, Martino G, Uccelli A, et al. Immunotherapy for neurological diseases. Clin Immunol. 2008;128:294.View ArticlePubMedGoogle Scholar
- Brandner S, Kleindienst A. Neuroprotection and neuroregeneration: what to expect from a stem cell-based therapy of acute brain injury. Crit Care Med. 2011;39:2577.View ArticlePubMedGoogle Scholar
- Kim SU, Jean DV. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res. 2009;87:2183.View ArticlePubMedGoogle Scholar
- Goulburn AL, Stanley EG, Elefanty AG, Anderson SA. Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cells. Stem Cell Res. 2012;8:416.View ArticlePubMedGoogle Scholar
- Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, et al. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington’s disease. Mol Neurobiol. 2012;45:87.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang Y, He W, Bian H, Liu C, Li S. Small molecule induction of neural-like cells from bone marrow-mesenchymal stem cells. J Cell Biochem. 2012;113:1527.PubMedGoogle Scholar
- Brustle O, McKay RG. Neuronal progenitors as tools for cell replacement in the nervous system. Curr Opin Neurobiol. 1996;6:688.View ArticlePubMedGoogle Scholar
- Sah DW, Ray J, Gage F. Bipotent progenitor cell lines from the human CNS. Nat Biotechnol. 1997;15:574.View ArticlePubMedGoogle Scholar
- Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, et al. Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes. Nat Biotechnol. 1998;16:1033.View ArticlePubMedGoogle Scholar
- Kim SU. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology. 2004;24:159.View ArticlePubMedGoogle Scholar
- Messmer K, Shen WB, Remington M, Fishman PS. Induction of neural differentiation by the transcription factor neuroD2. Int J Dev Neurosci. 2012;30:105.View ArticlePubMedGoogle Scholar
- Onoguchi M, Hirabayashi Y, Koseki H, Gotoh Y. A noncoding RNA regulates the neurogenin1 gene locus during mouse neocortical development. Proc Natl Acad Sci U S A. 2012;109:16939.View ArticlePubMedPubMed CentralGoogle Scholar
- Le MT, Xie H, Zhou B, Chia PH, Rizk P, Um M, et al. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol. 2009;29:5290.View ArticlePubMedPubMed CentralGoogle Scholar
- Agostini M, Tucci P, Killick R, Candi E, Sayan BS, Rivetti Di Val Cervo P, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A. 2011;108:21093.View ArticlePubMedPubMed CentralGoogle Scholar
- Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901.View ArticlePubMedGoogle Scholar
- Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000;408:86.View ArticlePubMedGoogle Scholar
- Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma. 2009;50:506.View ArticlePubMedGoogle Scholar
- Romao JM, Jin W, Dodson MV, Hausman GJ, Moore SS, Guan LL. MicroRNA regulation in mammalian adipogenesis. Exp Biol Med (Maywood). 2011;236:997.View ArticleGoogle Scholar
- Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129:303.View ArticlePubMedGoogle Scholar
- Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM, et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci U S A. 2004;101:360.View ArticlePubMedPubMed CentralGoogle Scholar
- Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. A microRNA array reveals extensive regulation of miRNAs during brain development. RNA. 2003;9:1274.View ArticlePubMedPubMed CentralGoogle Scholar
- Miska EA, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P, et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004;5:R68.1.View ArticleGoogle Scholar
- Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5:R13.1.View ArticleGoogle Scholar
- Yu JY, Chung KH, Deo M, Thompson RC, Turner DL. MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res. 2008;314:2618.View ArticlePubMedPubMed CentralGoogle Scholar
- Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 2007;27:435.View ArticlePubMedPubMed CentralGoogle Scholar
- Hohjoh H, Fukushima T. Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells. Biochem Biophys Res Commun. 2007;362:360.View ArticlePubMedGoogle Scholar
- Khoshnan A, Patterson PH. Elevated IKKα accelerates the differentiation of human neuronal progenitor cells and induces MeCP2-dependent BDNF expression. PLoS One. 2012;7:e41794.1.View ArticleGoogle Scholar
- Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A. 2006;103:2422.View ArticlePubMedPubMed CentralGoogle Scholar
- Maiorano NA, Mallamaci A. The pro-differentiating role of miR-124: indicating the road to become a neuron. RNA Biol. 2010;7:528.View ArticlePubMedGoogle Scholar
- Cao X, Pfaff SL, Gage FH. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007;21:531.View ArticlePubMedPubMed CentralGoogle Scholar
- Sanuki R, Onishi A, Koike C, Muramatsu R, Watanabe S, Muranishi Y, et al. miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat Neurosci. 2011;14:1125.View ArticlePubMedGoogle Scholar
- Samuel A, Gregory M. Molecular imaging, targeted therapeutics, and nanoscience. J Cell Biochem. 2002;87:90.View ArticleGoogle Scholar
- Fan-Minogue H, Cao Z, Paulmurugan R, Chan CT, Massoud TF, Felsher DW, et al. Noninvasive molecular imaging of c-Myc activation in living mice. Proc Natl Acad Sci U S A. 2010;107:15892.View ArticlePubMedPubMed CentralGoogle Scholar
- Kang JH, Chung JK. Molecular-genetic imaging based on reporter gene expression. J Nucl Med. 2008;49:164S.View ArticlePubMedGoogle Scholar
- Gloster A, Wu W, Speelman A, Weiss S, Causing C, Pozniak C, et al. The T alpha 1 alpha-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice. J Neurosci. 1994;14:7319.PubMedGoogle Scholar
- Miller FD, Naus CC, Durand M, Bloom FE, Milner RJ. Isotypes of alpha-tubulin are differentially regulated during neuronal maturation. J Cell Biol. 1987;105:3065.View ArticlePubMedGoogle Scholar
- Mizutani K, Yoon K, Dang L, Tokunaga A, Gaiano N. Differential Notch signalling distinguishes neural stem cells from intermediate progenitors. Nature. 2007;449:351.View ArticlePubMedGoogle Scholar
- Gloster A, El-Bizri H, Bamji SX, Rogers D, Miller FD. Early induction of Talpha1 alpha-tubulin transcription in neurons of the developing nervous system. J Comp Neurol. 1999;405:45.View ArticlePubMedGoogle Scholar
- Soprano DR, Teets BW, Soprano KJ. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm. 2007;75:69.View ArticlePubMedGoogle Scholar
- Ghil SH, Kim BJ, Lee YD, Suh-Kim H. Neurite outgrowth induced by cyclic AMP can be modulated by the alpha subunit of Go. J Neurochem. 2000;74:151.View ArticlePubMedGoogle Scholar
- Ng SY, Bogu GK, Soh BS, Stanton LW. The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis. Mol Cell. 2013;51:349.View ArticlePubMedGoogle Scholar
- Barbato C, Ruberti F, Cogoni C. Searching for MIND: microRNAs in neurodegenerative diseases. J Biomed Biotechnol. 2009;2009:871313.1.Google Scholar
- Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem. 2009;284:1971.View ArticlePubMedPubMed CentralGoogle Scholar
- Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, et al. A microRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317:1220.View ArticlePubMedPubMed CentralGoogle Scholar
- Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci. 2013;7:220.View ArticlePubMedPubMed CentralGoogle Scholar
- Magill ST, Cambronne XA, Luikart BW, Lioy DT, Leighton BH, Westbrook GL, et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A. 2010;107:20382.View ArticlePubMedPubMed CentralGoogle Scholar
- Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.View ArticlePubMedPubMed CentralGoogle Scholar
- Ko HY, Hwang Do W, Lee DS, Kim S. A reporter gene imaging system for monitoring microRNA biogenesis. Nat Protoc. 2009;4:1663.View ArticlePubMedGoogle Scholar
- Hwang Do W, Song IC, Lee DS, Kim S. Smart magnetic fluorescent nanoparticle imaging probes to monitor microRNAs. Small. 2010;6:81.View ArticlePubMedGoogle Scholar
- Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12:399.View ArticlePubMedPubMed CentralGoogle Scholar
- Åkerblom M, Sachdeva R, Barde I, Verp S, Gentner B, Trono D, et al. MicroRNA-124 is a subventricular zone neuronal fate determinant. J Neurosci. 2012;32:8879.View ArticlePubMedPubMed CentralGoogle Scholar
- Sawamoto K, Yamamoto A, Kawaguchi A, Yamaguchi M, Mori K, Goldman SA, et al. Direct isolation of committed neuronal progenitor cells from transgenic mice coexpressing spectrally distinct fluorescent proteins regulated by stage-specific neural promoters. J Neurosci Res. 2001;65:220.View ArticlePubMedGoogle Scholar
- Oh HJ, Hwang Do W, Youn H, Lee DS. In vivo bioluminescence reporter gene imaging for the activation of neuronal differentiation induced by the neuronal activator neurogenin 1 (Ngn1) in neuronal precursor cells. Eur J Nucl Med Mol Imaging. 2013;40:1607.View ArticlePubMedGoogle Scholar
- Kobat D, Durst ME, Nishimura N, Wong AW, Schaffer CB, Xu C. Deep tissue multiphoton microscopy using longer wavelength excitation. Opt Express. 2009;17:13354–64.View ArticlePubMedGoogle Scholar
- Park JH, Sun W, Cui M. High-resolution in vivo imaging of mouse brain through the intact skull. Proc Natl Acad Sci U S A. 2015;112:9236–41.View ArticlePubMedPubMed CentralGoogle Scholar